T. Ciuleanu : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (156)
Les plus populaires
Liste
- Liste
- Tableau

1

Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer

George Fountzilas, Elisabeta Ciuleanu, Urania Dafni, George Plataniotis, Anna Kalogera-Fountzila, Epaminontas Samantas, Eleni Athanassiou, John Tzitzikas, Tudor Ciuleanu, Angelos Nikolaou, Panayiotis

Journal:

Medical Oncology

Année:

2004

Langue:

english

Fichier:

PDF, 137 KB

english, 2004

2

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Nick Thatcher, Alex Chang, Purvish Parikh, José Rodrigues Pereira, Tudor Ciuleanu, Joachim von Pawel, Sumitra Thongprasert, Eng Huat Tan, Kristine Pemberton, Venice Archer, Kevin Carroll

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 158 KB

english, 2005

3

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

Tudor Ciuleanu, Thomas Brodowicz, Christoph Zielinski, Joo Hang Kim, Maciej Krzakowski, Eckart Laack, Yi-Long Wu, Isabel Bover, Stephen Begbie, Valentina Tzekova, Branka Cucevic, Jose Rodrigues Pereir

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 217 KB

english, 2009

4

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

Federico Cappuzzo, Tudor Ciuleanu, Lilia Stelmakh, Saulius Cicenas, Aleksandra Szczésna, Erzsébet Juhász, Emilio Esteban, Olivier Molinier, Wolfram Brugger, Ivan Melezínek, Gaëlle Klingelschmitt, Barb

Journal:

The Lancet Oncology

Année:

2010

Langue:

english

Fichier:

PDF, 321 KB

english, 2010

5

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non-Small-Cell Lung Cancer

Hirsch, F. R., Varella-Garcia, M., Bunn, P. A., Franklin, W. A., Dziadziuszko, R., Thatcher, N., Chang, A., Parikh, P., Pereira, J. R., Ciuleanu, T., von Pawel, J., Watkins, C., Flannery, A., Ellison,

Journal:

Journal of Clinical Oncology

Année:

2006

Langue:

english

Fichier:

PDF, 191 KB

english, 2006

6

A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC)

Grigorescu, Alexandru, Ciuleanu, Tudor, Firoiu, Elena, Muresan, Delia Ruta, Teodorescu, Gabriela, Basson, Bruce R.

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 249 KB

english, 2007

7

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

Paz-Ares, Luis, Mezger, Jörg, Ciuleanu, Tudor E, Fischer, Jürgen R, von Pawel, Joachim, Provencio, Mariano, Kazarnowicz, Andrzej, Losonczy, György, de Castro, Gilberto, Szczesna, Aleksandra, Crino, Lu

Journal:

The Lancet Oncology

Année:

2015

Langue:

english

Fichier:

PDF, 312 KB

english, 2015

8

FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study

Brodowicz, T., Ciuleanu, T. E., Radosavljevic, D., Shacham-Shmueli, E., Vrbanec, D., Plate, S., Mrsic-Krmpotic, Z., Dank, M., Purkalne, G., Messinger, D., Zielinski, C. C.

Journal:

Annals of Oncology

Année:

2013

Langue:

english

Fichier:

PDF, 214 KB

english, 2013

9

FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study

Kaczirek, Klaus, Ciuleanu, Tudor E., Vrbanec, Damir, Marton, Erika, Messinger, Diethelm, Liegl-Atzwanger, Bernadette, Wrba, Fritz, Knittelfelder, Regina, Lindner, Elisabeth, Zielinski, Christoph C., S

Journal:

Clinical Colorectal Cancer

Année:

2015

Langue:

english

Fichier:

PDF, 269 KB

english, 2015

10

Analysis of KRAS/NRAS Mutations in a Phase 3 Study of Panitumumab With FOLFIRI Compared With FOLFIRI Alone as Second-Line Treatment for Metastatic Colorectal Cancer

M. Peeters, K. Oliner, T. J. Price, A. Cervantes, A. F. Sobrero, M. Ducreux, Y. Hotko, T. Andre, E. Chan, F. Lordick, C. J. A. Punt, A. H. Strickland, G. Wilson, T. E. Ciuleanu, L. Roman, E. Van Cutse

Année:

2015

Langue:

english

Fichier:

PDF, 719 KB

english, 2015

11

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

Carbone, David P., Reck, Martin, Paz-Ares, Luis, Creelan, Benjamin, Horn, Leora, Steins, Martin, Felip, Enriqueta, van den Heuvel, Michel M., Ciuleanu, Tudor-Eliade, Badin, Firas, Ready, Neal, Hilterm

Journal:

New England Journal of Medicine

Année:

2017

Langue:

english

Fichier:

PDF, 545 KB

english, 2017

12

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Hellmann, Matthew D., Ciuleanu, Tudor-Eliade, Pluzanski, Adam, Lee, Jong Seok, Otterson, Gregory A., Audigier-Valette, Clarisse, Minenza, Elisa, Linardou, Helena, Burgers, Sjaak, Salman, Pamela, Borgh

Journal:

New England Journal of Medicine

Année:

2018

Langue:

english

Fichier:

PDF, 477 KB

english, 2018

13

Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data set

Grothey, Axel, Yoshino, Takayuki, Bodoky, Gyorgy, Ciuleanu, Tudor, Garcia-Carbonero, Rocio, García-Alfonso, Pilar, Van Cutsem, Eric, Muro, Kei, Mytelka, Daniel S, Li, Li, Lipkovich, Olga, Hsu, Yanzhi,

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 1.34 MB

english, 2018

14

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Ferris, R.L., Haddad, R., Even, C., Tahara, M., Dvorkin, M., Ciuleanu, T.E., Clement, P.M., Mesia, R., Kutukova, S., Zholudeva, L., Daste, A., Caballero-Daroqui, J., Keam, B., Vynnychenko, I., Lafond,

Journal:

Annals of Oncology

Année:

2020

Fichier:

PDF, 1.21 MB

2020

15

LBA59 First-line nivolumab (NIVO) + ipilimumab (IPI) combined with 2 cycles of platinum-based chemotherapy (chemo) vs 4 cycles of chemo in advanced non-small cell lung cancer (NSCLC): Patient-reported outcomes (PROs) from CheckMate 9LA

Reck, M., Ciuleanu, T-E., Cobo, M., Schenker, M., Zurawski, B., Menezes, J., Richardet, E., Bennouna, J., Cheng, Y., Paz-Ares, L., Lu, S., John, T., Padilla, B., Sun, X., Moisei, A., Yan, J., Yuan, Y.

Journal:

Annals of Oncology

Année:

2020

Fichier:

PDF, 124 KB

2020

16

Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy-induced anemia

Michael Auerbach, Peter T. Silberstein, R. Timothy Webb, Svetlana Averyanova, Tudor-Eliade Ciuleanu, James Shao, Kenneth Bridges

Journal:

American Journal of Hematology

Année:

2010

Langue:

english

Fichier:

PDF, 897 KB

english, 2010

17

Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients

Pol M. Specenier, Tudor Ciuleanu, Jane E. Latz, Luna C. Musib, Christelle L. S. Darstein, Jan B. Vermorken

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2009

Langue:

english

Fichier:

PDF, 341 KB

english, 2009

18

A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers

T. Ciuleanu, M. Diculescu, N. M. Hoepffner, J. Trojan, V. Sailer, M. Zalupski, T. Herrmann, A. Roth, J. Chick, K. Brock, D. Albert, P. A. Philip

Journal:

Investigational New Drugs

Année:

2007

Langue:

english

Fichier:

PDF, 244 KB

english, 2007

19

Consensus on the medical treatment of colon cancer

G. Kornek, W. Scheithauer, R. Anghel, G. Bodoky, F. Ciardiello, T. Ciuleanu, R. Glynne-Jones, T. Gruenberger, I. Koza, J. Ocvirk, L. Petruzelka, G. Poston, G. Ramadori, W. Schmiegel, S. Segaert, J. Ta

Journal:

memo - Magazine of European Medical Oncology

Année:

2008

Langue:

english

Fichier:

PDF, 215 KB

english, 2008

20

Profiling immunohistochemical expression of NOTCH1–3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary

Krikelis, Dimitrios, Pentheroudakis, George, Goussia, Anna, Siozopoulou, Vassiliki, Bobos, Mattheos, Petrakis, Dimitrios, Stoyianni, Aikaterini, Golfinopoulos, Vassilios, Cervantes, Andres, Ciuleanu,

Journal:

Clinical and Experimental Metastasis

Année:

2012

Langue:

english

Fichier:

PDF, 657 KB

english, 2012

21

A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella, Tudor Eliade Ciuleanu, G. Pover, N. C. Tebbutt

Journal:

Investigational New Drugs

Année:

2012

Langue:

english

Fichier:

PDF, 640 KB

english, 2012

22

Erratum to: A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella, Tudor Eliade Ciuleanu, G. Pover, N. C. Tebbutt

Journal:

Investigational New Drugs

Année:

2012

Langue:

english

Fichier:

PDF, 61 KB

english, 2012

23

Altered Left Ventricular Diastolic Performance in Oncologic Patients Treated With Epirubicin

Dan Radulescu, Sorin Pripon, Andreea Parv, Caius Duncea, Tudor E. Ciuleanu, Letitia I. Radulescu

Journal:

Congestive Heart Failure

Année:

2007

Langue:

english

Fichier:

PDF, 278 KB

english, 2007

24

Malignant Primary Pulmonary Tumor with Hemangiopericytoma-Like Features: Conventional Hemangiopericytoma Versus Solitary Fibrous Tumor

Dan Radulescu, Sorin Pripon, Tudor E. Ciuleanu, Letitia I. Radulescu

Journal:

Clinical Lung Cancer

Année:

2007

Langue:

english

Fichier:

PDF, 1.07 MB

english, 2007

25

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial

Ramlau, R., Gorbunova, V., Ciuleanu, T. E., Novello, S., Ozguroglu, M., Goksel, T., Baldotto, C., Bennouna, J., Shepherd, F. A., Le-Guennec, S., Rey, A., Miller, V., Thatcher, N., Scagliotti, G.

Journal:

Journal of Clinical Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 2.73 MB

english, 2012

26

Preparations for normalizing the elevated level of serical copper in oncopaediatry

C.C. Nistor, I.I. Marinescu, C.C.C. Nistor, M. Ujicǎ, V. Nistor, M. Onişor, M. Miron, R. Rǎdulescu, S. Neamţu, E. Ciuleanu, G.R. Popescu, D. Isai, D.N. Milea, N.N. Milea, I.I. Brie, M.I. Brie

Journal:

European Journal of Pharmacology

Année:

1990

Langue:

english

Fichier:

PDF, 118 KB

english, 1990

27

435 Neoadjuvant “BEC” and “EC” chemotherapy (CT) for locoregionally advanced undifferentiated nasopharyngeal carcinoma (UCNI)

T.E. Ciuleanu, N. Ghilezan, V. Cenea, E. Ciuleanu, N. Todor

Journal:

European Journal of Cancer

Année:

1995

Langue:

english

Fichier:

PDF, 152 KB

english, 1995

28

A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine

Tudor E. Ciuleanu, Alexander V. Pavlovsky, Gyorgy Bodoky, Avgust M. Garin, Virginia K. Langmuir, Stewart Kroll, George T. Tidmarsh

Journal:

European Journal of Cancer

Année:

2009

Langue:

english

Fichier:

PDF, 334 KB

english, 2009

29

1450 POSTER Immunohistochemical Profiling of Signalling Pathways in Cancer of Unknown Primary (CUP)

G. Pentheroudakis, D. Petrakis, A. Goussia, V. Siozopoulou, M. Bobos, G. Fountzilas, A. Cervantes, V. Malamou-Mitsi, T. Ciuleanu, N. Pavlidis

Journal:

European Journal of Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 41 KB

english, 2011

30

185 - Combination chemotherapy (CT) and secondary resection (SR) results in germ cell testicular cancer (TT)

C. Cebotaru, N. ghilezan, N. Todor, T.E. Ciuleanu

Journal:

European Journal of Cancer

Année:

1997

Langue:

english

Fichier:

PDF, 218 KB

english, 1997

31

829 - A comparative analysis between Ho's and UICC classification for nasopharyngeal carcinoma (NPC)

E. Ciuleanu, N. Ghilezan, N. Todor, T.E. Ciuleanu

Journal:

European Journal of Cancer

Année:

1997

Langue:

english

Fichier:

PDF, 430 KB

english, 1997

32

Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma (NPC)

E. Ciuleanu, T.E. Ciuleanu, V. Popita, N. Todor, A. Fodor, N. Ghilezan

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 160 KB

english, 1999

33

Taxol and cisplatin (TP) versus etoposide cisplatin (EP) in advanced non-small cell lung cancer (NSCLC)

T.E. Ciuleanu, C. Cebotaru, I. Radulescu, N. Todor, N. Ghilezan

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 317 KB

english, 1999

34

Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial

Cécile Le Péchoux, Ariane Dunant, Suresh Senan, Aaron Wolfson, Elisabeth Quoix, Corinne Faivre-Finn, Tudor Ciuleanu, Rodrigo Arriagada, Richard Jones, Rinus Wanders, Delphine Lerouge, Agnès Laplanche

Journal:

The Lancet Oncology

Année:

2009

Langue:

english

Fichier:

PDF, 194 KB

english, 2009

35

Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study

Chandra P Belani, Thomas Brodowicz, Tudor E Ciuleanu, Maciej Krzakowski, Sung Hyun Yang, Fábio Franke, Branka Cucevic, Jayaprakash Madhavan, Armando Santoro, Rodryg Ramlau, Astra M Liepa, Carla Visser

Journal:

The Lancet Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 230 KB

english, 2012

36

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study

Tudor Ciuleanu, Lilia Stelmakh, Saulius Cicenas, Skaidrius Miliauskas, Alexandru Calin Grigorescu, Carina Hillenbach, Hrefna Kristin Johannsdottir, Barbara Klughammer, Emilio Esteban Gonzalez

Journal:

The Lancet Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 381 KB

english, 2012

37

Second-line erlotinib for non-small-cell lung cancer – Authors' reply

Journal:

The Lancet Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 35 KB

english, 2012

38

Integration of surgery in the pluridisciplinary approach of non-small cell cancer patients improves the outcome

Ioan, A, Ciuleanu, T, Guttman, T, Ghilezan, N

Journal:

Année:

2000

Langue:

english

Fichier:

PDF, 117 KB

english, 2000

39

PL-3 Results of the randomized international adjuvant lung cancer trial (IALT): Cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (PTS) with resected non-small cell lung cancer (NSCLC)

Le Chevalier, T., Pignon, J.P., Bergman, B., Kozlowski, M., Orlowski, T., Pirker, R., Ciuleanu, T., Pinel, M.I. Sathler, Jackevicius, A., Vansteenkiste, J.

Journal:

Année:

2003

Langue:

english

Fichier:

PDF, 153 KB

english, 2003

40

P-209 Comparison of three cisplatin (P) doublets — Gemcitabine/P (GP), paclitaxel/P (TP), etoposide/P (EP) in advanced (stage IIIB and IV) non-small cell lung cancer (NSCLC)

Ciuleanu, Tudor E., Marian, Marisca, Todor, Nicolae, Cebotaru, Cristina, Iancu, Dana, Ghilezan, Nicolae

Journal:

Année:

2003

Langue:

english

Fichier:

PDF, 191 KB

english, 2003

41

P-524 Sequential combination of gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of stage III and IV non-small cell lung cancer. Preliminary results of a randomized phase II trial

Ciuleanu, Tudor, Firoiu, Elena, Grigorescu, Alexandru Calin, Muresan, Delia Ruta, Davidescu, Cristian, Ciochinaru, Mihai, Curca, Razvan, Rosca, Roberta, Teodorescu, Gabriela, Skacel, Tomas

Journal:

Année:

2003

Langue:

english

Fichier:

PDF, 168 KB

english, 2003

42

P-593 Concurrent chemoradiotherapy with navelbine and cisplatin for unresectable stage III NSCLC: A phase II study

Rusu, Petronela, Ciuleanu, Tudor Eliade, Cernea, Dana, Pelau, Doris, Gaal, Viola, Cebotaru, Cristina, Iancu, Dana, Guttman, Tiberiu, Todor, Nicolae, Ghilezan, Nicolae

Journal:

Année:

2003

Langue:

english

Fichier:

PDF, 196 KB

english, 2003

43

O-163 Prevention of thromboembolic complications with the low-molecular-weight heparin certoparin in non-small-cell lung carcinoma (TOPIC-2)

Gatzemeier, U., Freund, M., Haas, S., Kakkar, A., Zatloukal, P., Kelbel, C., Tchibisov, L., Shparyk, Y., Ciuleanu, T., Huisman, M.

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 148 KB

english, 2005

44

O-157 Survival benefit of oral topotecan plus supportive care versus supportive care alone in relapsed, resistant SCLC

O'Brien, M., Ciuleanu, T., Tsekov, H., Shparyk, Y., Cucevic, B., Juhasz, G., Ross, G., Dane, G., Crofts, T.

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 144 KB

english, 2005

45

P-223 A phase II study of concurrent chemoradiotherapy with navelbineand cisplatin for unresectable stage III NSCLC

Rusu, P., Ciuleanu, T., Cernea, D., Pelau, D., Gaal, V., Cebotaru, C., Guttman, T., Todor, N., Ghilezan, N.

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 148 KB

english, 2005

46

P-224 A phase II study of concurrent chemoradiotherapy with navelbineand cisplatin for unresectable stage III NSCLC

Rusu, P., Ciuleanu, T., Cernea, D., Pelau, D., Gaal, V., Cebotaru, C., Guttman, T., Todor, N., Ghilezan, N.

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 290 KB

english, 2005

47

P382 A randomized phase II trial of sequential gemcitabine plusvinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaïve patients with stage III and IV non-small cell lung cancer (NSCLC)

Teodorescu, G., Ciuleanu, T., Grigorescu, A., Firoiu, E., Ruta Muresan, D.

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 148 KB

english, 2005

48

88PD EFFICACY AND SAFETY OF ERLOTINIB VERSUS CHEMOTHERAPY IN SECOND-LINE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) WITH POOR PROGNOSIS: THE PHASE III TITAN STUDY

Ciuleanu, T., Stelmakh, L., Cicenas, S., Gonzalez, E. Esteban

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 74 KB

english, 2011

49

Noninvasive diagnostic work-up correlated with operative findings in non-small lung cell cancer (NSCLC) patients

Ioan, A, Ciuleanu, TE, Guttman, T, Barsan, M, Ghilezan, N

Journal:

Année:

1998

Langue:

english

Fichier:

PDF, 129 KB

english, 1998

50

PCN77 COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN ROMANIA

TE Ciuleanu, M Dediu, LN Minea, S Baculea, M Szkultecka-Debek

Journal:

Value in Health

Année:

2010

Langue:

english

Fichier:

PDF, 77 KB

english, 2010